article Open access
UNC13A Gene Brings New Hope for ALS Disease-Modifying Drugs
Xi Chena b, Heling Chuc d✉, Yi Donga e✉
- aDepartment of Neurology, National Center for Neurological Disorders, Huashan Hospital, Fudan University, Shanghai, 200040, China
- bDepartment of Neurology, National Center for Neurological Disorders, Huashan Hospital, Fudan University, Shanghai, China
- cDepartment of Gerontology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, 200233, China. chuheling85@163.com
- dDepartment of Gerontology, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, China
- eDepartment of Neurology, National Center for Neurological Disorders, Huashan Hospital, Fudan University, Shanghai, 200040, China. drdongyi@yeah.net
- ✉Corresponding author
Looking for the full paper…
Papers open inside SciRah from the original publisher or repository; SciRah never hosts them.
Abstract
No abstract is available from our sources. Use “Read paper” to view it.
TL;DRTheunc13A gene has been identified as a shared risk locus for ALS and FTD by genome-wide association studies, but the association between UNC13A and disease risk has not been elucidated, suggesting that ALS-causing mechanisms converge on this central pathological axis. (Semantic Scholar)